Physiology of the female reproductive axis

Periodontology 2000

Volumn 61, Issue 1, 2013, Pages 89-102

  Bates, G Wright ^a   Bowling, Meaghan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ENDOCRINE GLAND; FEMALE; FEMALE GENITAL SYSTEM; GYNECOLOGIC DISEASE; HUMAN; OVARY; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREMATURE OVARIAN FAILURE; UTERUS;

ENDOCRINE GLANDS; FEMALE; GENITAL DISEASES, FEMALE; GENITALIA, FEMALE; HUMANS; OVARY; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PRIMARY OVARIAN INSUFFICIENCY; UTERUS;

EID: 84871194667     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/j.1600-0757.2011.00409.x     Document Type: Article

References (83)

1. Adashi EY, Rock JA, Rosenwaks Z. Reproductive endocrinology, surgery, and technology. Philadelphia: Lippincott-Raven, 1996.
2. Allaerts W, Vankelecom H. History and perspectives of pituitary folliculo- stellate cell research. Eur J Endocrinol 2005: 153: 1-12.
3. American Congress of Obstetricians and Gynecologists. ACOG committee opinion. No. 338: screening for fragile X syndrome. Obstet Gynecol 2006: 107: 1483-1485.
4. American Society for Reproductive Medicine. Preimplantation genetic testing: a Practice Committee opinion. Fertil Steril 2007: 88: 1497-1504.
5. Bakalov VK, Vanderhoof VH, Bondy CA, Nelson LM. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum Reprod 2002: 17: 2096-2100.
6. Barba M, Schunemann HJ, Sperati F, Akl EA, Musicco F, Guyatt G, Muti P. The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis. Clin Endocrinol (Oxf) 2009: 70: 661-670.
7. Bates GW, Hill JA. Autoimmune premature ovarian failure. J Reprod Immunol 2002: 13: 65-79.
8. Besecke LM, Guendner MJ, Sluss PA, Polak AG, Woodruff TK, Jameson JL, Bauer-Dantoin AC, Weiss J. Pituitary follistatin regulates activin- mediated production of follicle-stimulating hormone during the rat estrous cycle. Endocrinology 1997: 138: 2841-2848.
9. Brannian JD, Stouffer RL. Cellular approaches to understand the function and regulation of the primate corpus luteum. Semin Reprod Endocinol 1991: 9: 341-351.
10. Braverman PK, Sondheimer SJ. Menstrual disorders. Pediatr Rev 1997: 18: 17-25.
11. Broekmans FJ, Knauff EA, Valkenburg O, Laven JS, Eijkemans MJ, Fauser BC. PCOS according to the Rotterdam consensus criteria: change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 2006: 113: 1210-1217.
12. Buhimschi CS. Endocrinology of lactation. Obstet Gynecol Clin North Am 2004: 31: 963-979, xii.
13. Burrows TD, King A, Loke YW. Trophoblast migration during human placental implantation. Hum Reprod Update 1996: 2: 307-321.
14. Catt KJ, Dufau ML, Vaitukaitis JL. Appearance of hCG in pregnancy plasma following the initiation of implantation of the blastocyst. J Clin Endocrinol Metab 1975: 40: 537-540.
15. Cohen PN, Givens JR, Wiser WL, Wilroy RS, Summitt RL, Coleman SA, Andersen RN. Polycystic ovarian disease, maturation arrest of spermiogenesis, and Klinefelter's syndrome in siblings of a family with familial hirsutism. Fertil Steril 1975: 26: 1228-1238.
16. Cooper DS. Clinical practice. Subclinical hypothyroidism. N Engl J Med 2001: 345: 260-265.
17. Corrigan EC, Raygada MJ, Vanderhoof VH, Nelson LM. A woman with spontaneous premature ovarian failure gives birth to a child with fragile X syndrome. Fertil Steril 2005: 84: 1508.
18. Creanga AA, Bradley HM, McCormick C, Witkop CT. Use of metformin in polycystic ovary syndrome: a meta-analysis. Obstet Gynecol 2008: 111: 959-968.
19. Crow J, Amso NN, Lewin J, Shaw RW. Morphology and ultrastructure of fallopian tube epithelium at different stages of the menstrual cycle and menopause. Hum Reprod 1994: 9: 2224-2233.
20. da Vinci L. Anatomical study (embryo). 1511. http://www.backtoclassics.com/gallery/leonardodavinci/anatomicalstudyembryo/ [accessed 18 March 2011].
21. DiNapoli L, Capel B. SRY and the standoff in sex determination. Mol Endocrinol 2008: 22: 1-9.
22. Dunaif A. Insulin resistance in women with polycystic ovary syndrome. Fertil Steril 2006: 86(Suppl. 1): S13-S14.
23. Eagleson CA, Bellows AB, Hu K, Gingrich MB, Marshall JC. Obese patients with polycystic ovary syndrome: evidence that metformin does not restore sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by ovarian steroids. J Clin Endocrinol Metab 2003: 88: 5158-5162.
24. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med 2005: 352: 1223-1236.
25. Erickson GF, Magoffin DA, Dyer CA, Hofeditz C. The ovarian androgen producing cells: a review of structure/function relationships. Endocr Rev 1985: 6: 371-399.
26. Falany JL, Falany CN. Regulation of estrogen sulfotransferase in human endometrial adenocarcinoma cells by progesterone. Endocrinology 1996: 137: 1395-1401.
27. Filicori M. The role of luteinizing hormone in folliculogenesis and ovulation induction. Fertil Steril 1999: 71: 405-414.
28. Filicori M, Santoro N, Merriam GR, Crowley WF Jr. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab 1986: 62: 1136-1144.
29. Fukuda M, Fukuda K, Andersen CY, Byskov AG. Characteristics of human ovulation in natural cycles correlated with age and achievement of pregnancy. Hum Reprod 2001: 16: 2501-2507.
30. Goland RS, Conwell IM, Warren WB, Wardlaw SL. Placental corticotropin- releasing hormone and pituitary-adrenal function during pregnancy. Neuroendocrinology 1992: 56: 742-749.
31. Goodman AL, Hodgen GD. The ovarian triad of the primate menstrual cycle. Recent Prog Horm Res 1983: 39: 1-73.
32. Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod 1986: 1: 81-87.
33. Gyamfi C, Wapner RJ, D'Alton ME. Thyroid dysfunction in pregnancy: the basic science and clinical evidence surrounding the controversy in management. Obstet Gynecol 2009: 113: 702-707.
34. Handwerger S. Clinical counterpoint: the physiology of placental lactogen in human pregnancy. Endocr Rev 1991: 12: 329-336.
35. Hellemans A, Bunch BH. The timetables of science: a chronology of the most important people and events in the history of science. New York, NY: Simon and Schuster, 1988.
36. Hillier SG. Intrafollicular paracrine function of ovarian androgen. J Steroid Biochem 1987: 27: 351-357.
37. Himelstein-Braw R, Byskov AG, Peters H, Faber M. Follicular atresia in the infant human ovary. J Reprod Fertil 1976: 46: 55-59.
38. Hoeger KM. Obesity and lifestyle management in polycystic ovary syndrome. Clin Obstet Gynecol 2007: 50: 277-294.
39. Irani RA, Xia Y. The functional role of the renin-angiotensin system in pregnancy and preeclampsia. Placenta 2008: 29: 763-771.
40. Irwin JC, Kirk D, Gwatkin RB, Navre M, Cannon P, Giudice LC. Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle. J Clin Invest 1996: 97: 438-447.
41. Iwashita M, Evans MI, Catt KJ. Characterization of a gonadotropin- releasing hormone receptor site in term placenta and chorionic villi. J Clin Endocrinol Metab 1986: 62: 127-133.
42. Kalantaridou SN, Calis KA, Mazer NA, Godoy H, Nelson LM. A pilot study of an investigational testosterone transdermal patch system in young women with spontaneous premature ovarian failure. J Clin Endocrinol Metab 2005: 90: 6549-6552.
43. Kirkland JL, Murthy L, Stancel GM. Progesterone inhibits the estrogen- induced expression of c-fos messenger ribonucleic acid in the uterus. Endocrinology 1992: 130: 3223-3230.
44. Kitaoka M, Kojima I, Ogata E. Activin-A: a modulator of multiple types of anterior pituitary cells. Biochem Biophys Res Commun 1988: 157: 48-54.
45. Kronquist KE, Sherman SL, Spector EB. Clinical significance of tri- nucleotide repeats in Fragile X testing: a clarification of American College of Medical Genetics guidelines. Genet Med 2008: 10: 845-847.
46. Legro RS, Barnhart HX, Schlaff WD, Carr BR, Diamond MP, Carson SA, Steinkampf MP, Coutifaris C, McGovern PG, Cataldo NA, Gosman GG, Nestler JE, Giudice LC, Leppert PC, Myers ER. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007: 356: 551-566.
47. Lindsay JR, Nieman LK. The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. Endocr Rev 2005: 26: 775-799.
48. Ludwig H, Spornitz UM. Microarchitecture of the human endometrium by scanning electron microscopy: menstrual desquamation and remodeling. Ann N Y Acad Sci 1991: 622: 28-46.
49. Mais V, Kazer RR, Cetel NS, Rivier J, Vale W, Yen SS. The dependency of folliculogenesis and corpus luteum function on pulsatile gonadotropin secretion in cycling women using a gonadotropin-releasing hormone antagonist as a probe. J Clin Endocrinol Metab 1986: 62: 1250-1255.
50. Markee JE. Menstruation in intraocular endometrial transplants in the Rhesus monkey. Am J Obstet Gynecol 1978: 131: 558-559.
51. McNatty KP, Makris A, DeGrazia C, Osathanondh R, Ryan KJ. The production of progesterone, androgens, and estrogens by granulosa cells, thecal tissue, and stromal tissue from human ovaries in vitro. J Clin Endocrinol Metab 1979: 49: 687-699.
52. Mesiano S, Katz SL, Lee JY, Jaffe RB. Insulin-like growth factors augment steroid production and expression of steroidogenic enzymes in human fetal adrenal cortical cells: implications for adrenal androgen regulation. J Clin Endocrinol Metab 1997: 82: 1390-1396.
53. Motta PM, Makabe S, Nottola SA. The ultrastructure of human reproduction. I. The natural history of the female germ cell: origin, migration and differentiation inside the developing ovary. Hum Reprod Update 1997: 3: 281-295.
54. Nippoldt TB, Reame NE, Kelch RP, Marshall JC. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle. J Clin Endocrinol Metab 1989: 69: 67-76.
55. North American Menopause Society. The role of calcium in peri- and postmenopausal women: 2006 position statement of the North American Menopause Society. Menopause 2006: 13: 862-877.
56. Palomba S, Falbo A, Zullo F, Orio F Jr. Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocr Rev 2009: 30: 1-50.
57. Parker CR Jr, Everett RB, Quirk JG Jr, Whalley PJ, Gant NF. Hormone production during pregnancy in the primigravid patient. I. Plasma levels of progesterone and 5-alpha-pregnane-3, 20-dione throughout pregnancy of normal women and women who developed pregnancy-induced hypertension. Am J Obstet Gynecol 1979: 135: 778-782.
58. Parker CR Jr, Illingworth DR, Bissonnette J, Carr BR. Endocrine changes during pregnancy in a patient with homozygous familial hypobetalipoproteinemia. N Engl J Med 1986: 314: 557-560.
59. Patel SS, Carrick KS, Carr BR. Virilization persists in a woman with an androgen-secreting granulosa cell tumor. Fertil Steril 2009: 91: 933 e13-15.
60. Pauerstein CJ, Eddy CA, Croxatto HD, Hess R, Siler-Khodr TM, Croxatto HB. Temporal relationships of estrogen, progesterone, and luteinizing hormone levels to ovulation in women and infrahuman primates. Am J Obstet Gynecol 1978: 130: 876-886.
61. Rabinovici J, Jaffe RB. Development and regulation of growth and differentiated function in human and subhuman primate fetal gonads. Endocr Rev 1990: 11: 532-557.
62. Rebar RW. Premature ovarian failure. Obstet Gynecol 2009: 113: 1355-1363.
63. Richards JS, Jahnsen T, Hedin L, Lifka J, Ratoosh S, Durica JM, Goldring NB. Ovarian follicular development: from physiology to molecular biology. Recent Prog Horm Res 1987: 43: 231-276.
64. Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 1987: 65: 1231-1237.
65. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007: 297: 1465-1477.
66. Rothchild I. Role of progesterone in initiating and maintaining pregnancy. In: Bardin CW, Milgröm E, Mauvais-Jarvis P editors. Progesterone and progestins. New York, NY: Raven Press, 1983: 219-229.
67. Sadler TW, Langman J. Langman's medical embryology, 11th edn. Philadelphia: Lippincott William & Wilkins, 2010.
68. Sam S, Frohman LA. Normal physiology of hypothalamic pituitary regulation. Endocrinol Metab Clin North Am 2008: 37: 1-22, vii.
69. Schipper I, Hop WC, Fauser BC. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development. J Clin Endocrinol Metab 1998: 83: 1292-1298.
70. Schrier RW. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. Am J Med 2006: 119: S47-S53.
71. Shahab M, Mastronardi C, Seminara SB, Crowley WF, Ojeda SR, Plant TM. Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates. Proc Natl Acad Sci U S A 2005: 102: 2129-2134.
72. Shroff R, Syrop CH, Davis W, Van Voorhis BJ, Dokras A. Risk of metabolic complications in the new PCOS phenotypes based on the Rotterdam criteria. Fertil Steril 2007: 88: 1389-1395.
73. Siiteri PK, MacDonald PC. The utilization of circulating dehydroisoandrosterone sulfate for estrogen synthesis during human pregnancy. Steroids 1963: 2: 713-730.
74. Smout CFV, Jacoby F, Lillie EW. Gynecological and obstetrical anatomy, descriptive & applied. Baltimore: Williams & Wilkins, 1969.
75. Speroff L, Fritz MA. Clinical gynecologic endocrinology and infertility, 7th edn. Philadelphia: Lippincott Williams & Wilkins, 2005.
76. Tabibzadeh S. The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling. Mol Hum Reprod 1996: 2: 77-92.
77. Tao A. How the myosalpinx works in gamete and embryo transfer. Arch Biol Med Exp 1991: 24: 361-375.
78. Taran FA, Weaver AL, Coddington CC, Stewart EA. Understanding adenomyosis: a case control study. Fertil Steril 2010: 94: 1223-1228.
79. Taylor E, Gomel V. The uterus and fertility. Fertil Steril 2008: 89: 1-16.
80. Vande Wiele RL, Bogumil J, Dyrenfurth I, Ferin M, Jewelewicz R, Warren M, Rizkallah T, Mikhail G. Mechanisms regulating the menstrual cycle in women. Recent Prog Horm Res 1970: 26: 63-103.
81. Vigorito C, Giallauria F, Palomba S, Cascella T, Manguso F, Lucci R, De Lorenzo A, Tafuri D, Lombardi G, Colao A, Orio F. Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007: 92: 1379-1384.
82. Waldstreicher J, Santoro NF, Hall JE, Filicori M, Crowley WF Jr. Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization. J Clin Endocrinol Metab 1988: 66: 165-172.
83. Waldstreicher J, Seminara SB, Jameson JL, Geyer A, Nachtigall LB, Boepple PA, Holmes LB, Crowley WF Jr. The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human. J Clin Endocrinol Metab 1996: 81: 4388-4395.